Market News

Gofen & Glossberg Cut By $358,542 Its Western Union (WU) Stake; Oramed Pharmaceuticals (ORMP)’s Sentiment Is 2.75

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Logo

Oramed Pharmaceuticals Inc (ORMP) investors sentiment increased to 2.75 in 2017 Q4. It’s up 0.75, from 2 in 2017Q3. The ratio is more positive, as 11 investment managers opened new and increased stock positions, while 4 cut down and sold stock positions in Oramed Pharmaceuticals Inc. The investment managers in our database now hold: 329,110 shares, up from 255,973 shares in 2017Q3. Also, the number of investment managers holding Oramed Pharmaceuticals Inc in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 3 Increased: 7 New Position: 4.

Gofen & Glossberg Llc decreased Western Union (WU) stake by 40.98% reported in 2017Q4 SEC filing. Gofen & Glossberg Llc sold 19,919 shares as Western Union (WU)’s stock declined 1.00%. The Gofen & Glossberg Llc holds 28,692 shares with $545,000 value, down from 48,611 last quarter. Western Union now has $8.94B valuation. The stock increased 0.21% or $0.04 during the last trading session, reaching $19.41. About 3.26 million shares traded. The Western Union Company (NYSE:WU) has declined 5.69% since April 20, 2017 and is downtrending. It has underperformed by 17.24% the S&P500.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company has market cap of $103.19 million. The Company’s product portfolio includes ORMD-0801, an oral insulin capsule, which has completed Phase IIb clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which has completed Phase Ib clinical trials for the treatment of type 2 diabetes. It currently has negative earnings. The firm operates primarily in Israel.

Bank Of America Corp De holds 0% of its portfolio in Oramed Pharmaceuticals Inc. for 1,117 shares. Bank Of Montreal Can owns 2,600 shares or 0% of their US portfolio. Moreover, Barclays Plc has 0% invested in the company for 41,186 shares. The Germany-based Deutsche Bank Ag has invested 0% in the stock. Financial Architects Inc, a New Jersey-based fund reported 2,750 shares.

The stock decreased 3.18% or $0.24 during the last trading session, reaching $7.14. About 12,616 shares traded. Oramed Pharmaceuticals Inc. (ORMP) has risen 11.98% since April 20, 2017 and is uptrending. It has outperformed by 0.43% the S&P500.

Since January 8, 2018, it had 0 insider purchases, and 2 insider sales for $1.44 million activity. Schenkel Amintore also sold $343,044 worth of The Western Union Company (NYSE:WU) shares. Another trade for 50,813 shares valued at $1.09 million was made by Farah Jean Claude on Monday, January 8.

Analysts await The Western Union Company (NYSE:WU) to report earnings on May, 1 after the close. They expect $0.42 earnings per share, up 20.00% or $0.07 from last year’s $0.35 per share. WU’s profit will be $193.45 million for 11.55 P/E if the $0.42 EPS becomes a reality. After $0.41 actual earnings per share reported by The Western Union Company for the previous quarter, Wall Street now forecasts 2.44% EPS growth.

Gofen & Glossberg Llc increased Intuitive Surgical (NASDAQ:ISRG) stake by 1,323 shares to 1,950 valued at $712,000 in 2017Q4. It also upped Vanguard S/T Corp Bond (VCSH) stake by 4,867 shares and now owns 11,474 shares. Merck (NYSE:MRK) was raised too.

The Western Union Company (NYSE:WU) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *